These actions and the present in vivo results showing prevention and reversal of BFCN degeneration are consistent with the idea that LM11A-31 can bind to p75NTR to simultaneously increase survival signaling while decreasing degenerative signaling to ameliorate mid- to late-stage AD-related pathology. The gene discussed is NGFR; the disease is Alzheimer disease.